BioXcel Therapeutics Receives FDA Orphan Drug Designation for BXCL701 for the Treatment of Acute Myeloid Leukemia (AML)

September 4, 2019

We're not around right now. But you can send us an email and we'll get back to you, asap.

Start typing and press Enter to search